We are thrilled to announce that UniUni has successfully raised $30 million in its latest funding round, a significant milestone that will propel the company's mission to transform the delivery landscape in North America. Founded in 2019, UniUni has quickly established itself as a key player in the logistics sector, partnering with some of the world's leading international logistics providers to craft a unique delivery solution tailored for the modern eCommerce era. This new capital will enable UniUni to expand its innovative delivery model, further enhance its cutting-edge technology, and scale its operations, driving efficiency and reliability in the last-mile delivery process. As eCommerce continues to surge, UniUni remains committed to providing businesses of all sizes with the most reliable, affordable, and flexible service available. Each day, we are proud to move tens of thousands of parcels safely from businesses directly to consumers' doorsteps, fostering growth and success for eCommerce companies across North America. With this latest funding injection, we anticipate bolstering our logistics network, improving delivery speed, and enhancing the overall customer experience to meet the ever-evolving demands of the market. The future looks bright for UniUni, and we invite our partners and customers to join us on this exciting journey as we continue to innovate and lead the way in transforming last-mile logistics.

UniUni Secures $30 Million in Series C Funding to Transform Last-Mile Delivery in North America
Get the full UniUni company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Handle.com
Fortune 500 material suppliers and contractors trust Handle software on a daily basis to provide their credit and finance departments with an end-to-end solution. Purpose-built for material suppliers and equipment dealers to manage the entire process of online payments and lien management.
$27.0M Series b
today

Texas Automated Robotics Systems, LLC
Tars Robotics, based in Houston Texas, strives to equip manufacturers with the highest quality robotic automation equipment at the most economical value in the industry. Our goal is to enable as many American manufacturers with the ability to compete in the global injection molding industry. We continue to support the initiative to re-shore products from all industries back to the United States. We offer a wide and unique line of robotic arms for machines ranging from 30 tons to 4,000 tons while providing the best solutions no matter how intelligible or complex. With our customer’s need in mind, our product lines include a diverse series of robots designed for sprue and parts removal, insert molding, de-gating, in-mold labeling, and parts stacking.
$513.0M Seed
today

Viseur AI - Digital Pathology Platform
Viseur AI is a digital pathology and medical imaging platform built to become the operating system of AI-enabled diagnostics. We unify Pathology Information Management (PIMS), Digital Pathology / WSI viewing (IMS), AI model deployment and governance, and enterprise-grade integrations into a single, vendor-agnostic platform designed for real clinical workflows. Healthcare systems and diagnostic labs struggle with fragmented pathology workflows, scanner-locked software, and AI solutions that rarely reach routine clinical use. Viseur AI addresses this by delivering an end-to-end digital pathology platform from specimen to report, combining enterprise-grade WSI viewing, AI model deployment and management, on-prem or hybrid architectures aligned with data privacy and regulatory requirements, and deep LIS, HIS, and PACS integrations that enable standardised and scalable operations across multiple sites. Certified under ISO 13485, ISO 27001, and ISO/IEC 15504-SPICE, Viseur AI creates a foundation for clear and compatible AI in healthcare.
$350.0K Seed
today

Imperagen
Imperagen is advancing enzyme engineering through an integrated, AI-driven platform that enables faster and more precise development of high-performance enzymes. By combining advanced computational modeling with automated lab testing, we help companies improve production processes while reducing cost, time, and environmental impact. Founded by researchers from the Manchester Institute of Biotechnology, Imperagen brings together expertise in physics-based simulation, machine learning, and high-throughput experimentation. Our closed-loop platform continuously learns from real-world data, allowing us to design, test, and refine enzymes with greater accuracy and efficiency than traditional approaches . We take a problem-specific approach, tailoring each solution to the unique requirements of a given enzyme, reaction, and application. We work with organizations across pharma, life sciences, chemicals, food, and consumer goods to solve complex enzyme engineering challenges. Our approach helps reduce development risk, shorten timelines, and support the shift toward more sustainable, enzyme-based manufacturing. Get in touch to learn more about our innovative platform and discover how we can quickly transform your enzyme needs into market-ready solutions.
$6.4M Seed
today

Omni
Omni is an AI analytics platform that empowers everyone—regardless of technical ability—to easily analyze data using AI, spreadsheets, SQL, or point-and-click interfaces. It is built on a semantic layer that makes sure every insight is accurate and dependable. Beyond powering internal analytics, Omni makes it easy for businesses to offer highly customizable in-product analytics to their customers.
$120.0M Series c
today
Other recent Series c rounds
Companies that recently closed a Series c round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | ![]() Omni United States | Series c | $120.0M | today |
| 2 | ![]() Moment | Series c | $78.0M | today |
| 3 | ![]() Exa United States | Series c | $250.0M | 1d ago |
| 4 | ![]() Socket United States | Series c | $60.0M | 1d ago |
| 5 | ![]() Pluang Indonesia | Series c | $10.0M | 3d ago |



